<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01220011</url>
  </required_header>
  <id_info>
    <org_study_id>K090601</org_study_id>
    <secondary_id>ID RCB : 2010-A00026-33</secondary_id>
    <nct_id>NCT01220011</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery</brief_title>
  <acronym>TTTS1</acronym>
  <official_title>A Cluster Randomized Trial Comparing a Conservative Management and Primary Laser Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this trial is to compare both strategies (Expectative Vs Fetoscopic laser
      surgery) for patients with stage 1 TTTS and favorable obstetrical parameters in an
      international randomized controlled trial. This trial will answer an important question and
      will help in the management and tailoring of surgical indications in stage 1 TTTS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although we demonstrated the overall benefit of fetoscopic laser surgery as first-line
      treatment in twin-twin transfusion syndrome (TTTS), indications in early stage TTTS are
      controversial. Indeed, a conservative management with close follow-up is offered in some
      centers as first-line management for QUINTERO stage 1 TTTS, although this strategy has not
      been formally compared to first-line fetoscopic placental surgery. The objective of this
      trial is to compare both strategies for patients with stage 1 TTTS and favorable obstetrical
      parameters in an international randomized controlled trial. Patients randomized to a
      conservative management will be followed on a weekly basis as long as the syndrome remains
      stable using obstetrical and fetal parameters and until an adequate gestational age is
      reached allowing delivery. Cases progressing to stage ≥ 2 or with a worsening of obstetrical
      parameters during follow-up in this group will be actively treated by percutaneous laser
      coagulation. Patients allocated to the &quot;immediate laser&quot; group will be treated by fetoscopic
      laser surgery within 24 h following randomization. The primary end-point encompasses survival
      and neurological morbidity at the age of 6 months for each foetus randomized. Analyses and
      power computations use a cluster-trial methodology that accounts for the inter-twin
      correlation, with many benefits over more traditional designs using a per-pregnancy outcome.
      With proportions of 60% and 75% meaning a clinically relevant difference of 15% between the
      groups, 200 fetuses or equivalently 100 pregnancies would be needed in each arm to reach a
      power of 80% with an alpha-risk of 5%, allowing 2 interim analyses based upon LAN-DEMETS
      boundaries and an O'Brien-Fleming function. Inclusion criteria, interventions and
      randomisation were investigated through a preliminary survey across potential participating
      centers. Based on this survey, it is anticipated that 3 years will be needed to achieve the
      requested number of patients. This trial will answer an important question and will help in
      the management and tailoring of surgical indications in stage 1 TTTS.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>survival and neurological morbidity at the age of 6 months for each foetus randomized</measure>
    <time_frame>6 MONTHS</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">142</enrollment>
  <condition>Blood and Blood Disorders</condition>
  <condition>Anemia, Neonatal</condition>
  <condition>Hematologic Disease</condition>
  <condition>Infant, Newborn, Diseases</condition>
  <arm_group>
    <arm_group_label>NO INTERVENTION</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>fetoscopic laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fetoscopic laser surgery</intervention_name>
    <description>Fetoscopic laser surgery</description>
    <arm_group_label>NO INTERVENTION</arm_group_label>
    <arm_group_label>fetoscopic laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  TTTS stage 1 (Euro foetus criteria)

          -  Gestational age &gt; 16 and &lt; 26 weeks

          -  Age &gt; 18

          -  Informed consent

        Exclusion Criteria:

          -  Therapeutic amniocentesis prior to referral

          -  Short cervix &lt; 15 mm on transvaginal US

          -  Severe maternal discomfort:Dyspnea and orthopnea, Abdominal pain &gt; 4 on a 10-level
             visual analogic pain scale, Contractions &gt; 1 per hour

          -  PPROM

          -  Fetal malformations unrelated to TTTS

          -  Follow-up is impossible
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves VILLE, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yves Ville, PUPH</last_name>
    <email>Yville@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Hospital Colorado and Colorado Fetal Care Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Timothy M. Crombleholme, MD</last_name>
      <phone>855-413-3825</phone>
    </contact>
    <investigator>
      <last_name>Timothy M. Crombleholme, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of MD /Department of Obstetrics, Gynecology &amp; Reproductive Sciences</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ahmet Baschet, MD</last_name>
      <phone>410-328-7850</phone>
    </contact>
    <investigator>
      <last_name>Ahmet Baschet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fetal Care Center of Cincinnati, Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229-3026</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Foong-Yen Lim, MD</last_name>
      <phone>888-338-2559</phone>
    </contact>
    <investigator>
      <last_name>Foong-Yen Lim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University / OSU Fetal Therapy Program</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard W. O'Shaughnessy, MD</last_name>
      <phone>614-293-8083</phone>
    </contact>
    <investigator>
      <last_name>Richard W. O'Shaughnessy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Moldenhauer, MD</last_name>
      <phone>800-468-8376</phone>
    </contact>
    <investigator>
      <last_name>Julie Moldenhauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fetal Treatment Program of New England, Hasbro Children's Hospital, The Warren Alpert Medical School of Brown University.</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François I Luks, MD, PHD</last_name>
      <phone>401-228-0559</phone>
    </contact>
    <investigator>
      <last_name>François I Luks, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Texas Fetal Center, Children's Memorial Hermann Hospital, University of Texas Medical School</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Johnson, DO</last_name>
      <phone>832-325-7288</phone>
    </contact>
    <investigator>
      <last_name>Anthony Johnson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fetal Therapy Program, Evergrenn Hospital Medical Center</name>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mertin Walker, MD</last_name>
      <phone>425-899-3537</phone>
    </contact>
    <investigator>
      <last_name>Martin Walker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital, University of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>ON M5X 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Greg RYAN, MB</last_name>
      <phone>416-586-8415</phone>
    </contact>
    <investigator>
      <last_name>Greg Ryan, MB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Ste-Justine</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1R2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François Audibert, MD, Msc</last_name>
      <phone>514-345-7768</phone>
    </contact>
    <investigator>
      <last_name>François Audibert, MD, Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75006</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YVES VILLE, PU-PH</last_name>
      <phone>+33 (0)1 44 49 40 30</phone>
      <phone_ext>+33</phone_ext>
      <email>Yville@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2010</study_first_submitted>
  <study_first_submitted_qc>October 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2010</study_first_posted>
  <last_update_submitted>December 20, 2016</last_update_submitted>
  <last_update_submitted_qc>December 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fetoscopic Laser surgery</keyword>
  <keyword>Stage 1 Twin - twin transfusion syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematologic Diseases</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
    <mesh_term>Anemia, Neonatal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

